HALEON PLC (HLNCF) Financials

HLNCF Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 34.1 billion 17.3 billion
2023-09-30 ? ?
2023-06-30 34.2 billion 17.6 billion
2023-03-31 ? ?

HLNCF Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 ? ?
2023-06-30 ? ?
2023-03-31 ? ?

HLNCF Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -3.0 million
2023-09-30 365.0 million
2023-06-30 298.0 million
2023-03-31 389.0 million

HLNCF Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.0 billion - -
2023-09-30 - - -
2023-06-30 490.0 million - 146.0 million
2023-03-31 - - -

HLNCF Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 9.2 billion
2023-09-30 9.2 billion
2023-06-30 9.3 billion
2023-03-31 9.3 billion

HLNCF Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 94.0 million 1.1 billion -
2023-09-30 - 75.0 million 1.1 billion -
2023-06-30 - 67.0 million 1.1 billion -
2023-03-31 - 75.0 million 1.1 billion -

HLNCF Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.8 billion 1.3 billion
2023-09-30 2.8 billion 1.1 billion
2023-06-30 2.8 billion 1.0 billion
2023-03-31 3.0 billion 1.1 billion

HLNCF

Price: $4.09

52 week price:
3.81
4.50

Dividend Yield: 1.84%

5-year range yield:
1.14%
2.55%

Forward Dividend Yield: 2.60%

Payout Ratio: 75.86%

Payout Ratio Range:
75.86%
75.86%

Dividend Per Share: 0.11 USD

Earnings Per Share: 0.14 USD

P/E Ratio: 29.38

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 37.6 billion

Years Paying Dividends: 2

Links: